2011 Program

Sun, 11/06

6:00 PM – 8:00 PM
6:30 PM – 8:00 PM

Mon, 11/07

7:00 AM – 7:00 PM
8:00 AM – 9:00 AM
Opening Plenary Session: Priming The Pump: Filling the Therapeutic Pipeline
  • Margaret Anderson
    Executive Director, FasterCures/The Center for Accelerating Medical Solutions

  • Jeffrey Brewer
    President and CEO, Juvenile Diabetes Research Foundation
  • Susan Desmond-Hellmann
    Chancellor, University of California, San Francisco
  • Margaret A. Hamburg
    Commissioner, U.S. Food and Drug Administration
  • John Mendlein
    Executive Chairman, Fate Therapeutics and Chairman, aTyr Pharma
  • Garry Neil
    Corporate Vice President, Corporate Office of Science and Technology, Johnson & Johnson
9:15 AM – 10:10 AM
Panel - Back to Basics: Patient Activism Thirty Years After HIV/AIDS
  • Susan Love
    President and Medical Director, Dr. Susan Love Research Foundation

  • Maureen Byrnes
    Former Executive Director of the National Commission on AIDS
  • Warren B. Lammert
    Chairman and Co-Founder, The Epilepsy Therapy Project
  • Michael Manganiello
    Partner, HCM Strategists
  • Josh Sommer
    Executive Director, Chordoma Foundation
Panel - Living and Working in the Precompetitive Space
  • Steve Usdin
    Senior Editor (Washington), BioCentury

  • Aled M. Edwards
    Chief Executive, Structural Genomics Consortium
  • Hoyoung Huh
    Chairman of the Board, Geron Corporation
  • Daniel Laster
    General Counsel, Legal Affairs, PATH
  • Susan Rohrer
    Senior Director, External Scientific Affairs, Worldwide Licensing, Merck Research Laboratories
  • David Steinberg
    Partner, PureTech Ventures
Panel - What is NIH's Role in Bridging the Valley of Death?
  • Anna Barker
    Director, Transformative Healthcare Networks, Co-Director, Complex Adaptive Systems Initiative and Professor, School of Life Sciences, Arizona State University

  • Louis DeGennaro
    Chief Mission Officer, Leukemia & Lymphoma Society
  • Garret FitzGerald
    Robert L. McNeil, Jr., Professor in Translational Medicine and Therapeutics, University of Pennsylvania
  • Kathy Hudson
    Deputy Director for Science, Outreach, and Policy, National Institutes of Health
  • Peter Lansbury, Jr.
    Chief Scientific Officer, LINK Medicine and Professor of Neurology, Harvard Medical School
  • Chris Varma
    Entrepreneur-in-Residence, Third Rock Ventures
9:15 AM – 11:40 AM
12:00 PM – 1:30 PM
The Intersection of Human, Social, and Financial Capital
  • Michael Milken
    Chairman, Milken Institute and Chairman, FasterCures

  • Leon Black
    Co-Founder, Melanoma Research Alliance, Board Member, FasterCures, CEO, Apollo Management LP
  • Michael Cembalest
    Global Head of Investment Strategy, J.P. Morgan
  • Jason Cummins
    Chief U.S. Economist and Head of Research, Brevan Howard Inc
1:45 PM – 6:00 PM
3:45 PM – 4:40 PM
Panel - Business Is from Mars, Academia Is from Venus
  • Ross C. DeVol
    Chief Research Officer, Milken Institute

  • Anthony Coyle
    Vice President and CSO, Centers for Therapeutic Innovation, Pfizer, Inc.
  • Stephen Friend
    President, Sage Bionetworks
  • Annette Kleiser
    Senior Program Officer, Industry Initiatives, USC Stevens Institute for Innovation, University of Southern California
  • Fernando Kreutz
    Founder and President, FK-Biotec
  • Todd Sherer
    Chief Executive Officer, Michael J. Fox Foundation for Parkinson's Research
Panel - Experiments in Financing Early-Stage R & D
  • Chris Morrison
    Editor-in-Chief, Biopharmaceuticals and Consumer Products at Elsevier Business Intelligence

  • Timothy Coetzee
    Chief Research Officer, National Multiple Sclerosis Society
  • George Golumbeski
    Senior Vice President of Business Development, Celgene Corporation
  • Gwen A. Melincoff
    Senior Vice President, Business Development, Strategic Investment Group, Shire Pharmaceuticals
  • Dennis G. Podlesak
    Partner, Domain Associates
  • Melissa Stevens
    Director of Strategic Initiatives, FasterCures
Panel - Intellectual Property: The Negotiators' Debate
  • Debra R. Lappin
    President, Council for American Medical Innovation; Senior Vice President, B&D Consulting

  • Labeeb Abboud
    Senior Vice President and General Counsel, International AIDS Vaccine Initiative
  • James McCullough
    Chief Executive Officer, Exosome Diagnostics, Inc.
  • Teri Melese
    Associate Professor of Medicine and Director of Research Technologies and Alliances, School of Medicine, Dean's Office, University of California, San Francisco
  • Ken Schaner
    Managing Partner, Schaner & Lubitz
6:00 PM – 7:30 PM

Tue, 11/08

7:00 AM – 3:00 PM
8:00 AM – 9:00 AM
Plenary - Who Will Pay for Tomorrow's Medical Breakthroughs?
  • Margaret Anderson
    Executive Director, FasterCures/The Center for Accelerating Medical Solutions

  • Brook Byers
    Partner, Kleiner Perkins Caufield & Byers
  • Ron Cohen
    President and Chief Executive Officer, Acorda Therapeutics, Inc
  • Michael Rawlins
    Chairman, National Institute of Health and Clinical Excellence
  • Ellen V. Sigal
    Chair and Founder, Friends of Cancer Research
  • Reed Tuckson
    Executive Vice President and Chief of Medical Affairs, UnitedHealth Group
9:15 AM – 10:10 AM
Panel - Philanthropy as Risk Capital
  • Katie Hood
    Senior Fellow and Visiting Lecturer, Hart Leadership Program at Duke University's Sanford School of Public Policy

  • Rashmi Barbhaiya
    Chief Executive Officer and Managing Director, Advinus Therapeutics
  • N. Anthony Coles
    President, Chief Executive Officer and Member of the Board, Onyx Pharmaceuticals
  • Susan Wolf Ditkoff
    Partner, The Bridgespan Group
  • Howard Fillit
    Executive Director, Alzheimer's Drug Discovery Foundation
  • George Vradenburg
    Chairman, USAgainstAlzheimer's
Panel - Staying Afloat in a Sea of Data
  • Kris Joshi
    Global Vice President - Healthcare, Oracle

  • Eileen Bartholomew
    Senior Director, Life Sciences, X PRIZE Foundation
  • Brent Gendleman
    President and Chief Executive Officer, 5AM Solutions
  • David M. Margulies
    Senior Associate in Medicine and Director of The Gene Partnership (TGP), Children's Hospital Boston
  • Gerald McDougall
    Principal, Personalized Medicine and Health Sciences Practices,PricewaterhouseCoopers
  • Sean Nolan
    Chief Architect and General Manager, Health Solutions Group, Microsoft Corp.
Panel - Streamlining Drug Repurposing and Approval
  • Lesa Mitchell
    Vice President, Ewing Marion Kauffman Foundation

  • Michael Beckloff
    President, Beckloff Associates, Inc.
  • Regis B. Kelly
    Director, The California Institute for Quantitative Biosciences (QB3), University of California
  • Stephen P. Spielberg
    Deputy Commissioner for Medical Products and Tobacco, U.S. Food and Drug Administration
  • Scott J. Weir
    Director, Institute for Advancing Medical Innovation, University of Kansas Cancer Center
9:15 AM – 12:40 PM
11:45 AM – 12:40 PM
Panel - Convergence: The Death of Disciplinary Science?
  • Greg Simon
    Senior Vice President, Patient Engagement, Pfizer Inc.

  • Paula Hammond
    Bayer Chair Professor of Chemical Engineering, Massachusetts Institute of Technology
  • Thomas Kalil
    Deputy Director for Policy, White House Office of Science and Technology Policy
  • Larry A. Nagahara
    Acting Director, Office of Physical Sciences-Oncology, National Cancer Institute
  • George Poste
    Chief Scientist, Complex Adaptive Systems Initiative, Arizona State University
  • Raul Rabadan
    Assistant Professor, Department of Biomedical Informatics, Center for Computational Biology and Bioinformatics, Columbia University College of Physicians and Surgeons
Panel - Regulating Risk: Clearing New Pathways for Progress at FDA
  • Ramsey Baghdadi
    Managing Editor, The RPM Report

  • Robert J. Beall
    President and CEO, Cystic Fibrosis Foundation
  • James C. Greenwood
    President and CEO, Biotechnology Industry Organization (BIO)
  • Jonathan Leff
    Managing Director, Healthcare, Warburg Pincus
  • Jeffrey Shuren
    Director, Center for Devices and Radiological Health, U.S. Food and Drug Administration
Panel - The Future of Research: The Kids Are Alright
  • Wendy Selig
    President and CEO, Melanoma Research Alliance

  • Timothy N. Bullock
    Associate Professor, Department of Pathology Human Immune Therapy Center, University of Virginia
  • Valentina Fossati
    New York Stem Cell Foundation - Helmsley Investigator, The New York Stem Cell Foundation Laboratory
  • Sebastian Seung
    Professor of Computational Neuroscience, MIT; author of Connectome: How the Brain's Wiring Makes Us Who We Are
  • Padmanee Sharma
    Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
  • Brent Stockwell
    Associate Professor, Biological Science, Columbia University
1:00 PM – 2:30 PM
Plenary - Collaboration: Secrets of Success
  • Enriqueta (Queta) Bond
    Partner, QE Philanthropic Advisors

  • Gordon R. Bernard
    Professor of Medicine, Associate Vice Chancellor for Research, and Senior Associate Dean for Clinical Science, Vanderbilt University
  • Kathy Giusti
    Founder and Chief Executive Officer, Multiple Myeloma Research Foundation
  • Brian Harvey
    Vice President, U.S. Regulatory Policy, Sanofi
  • Thomas R. Insel
    Director, National Institute of Mental Health (NIMH), National Institutes of Health
  • Jeffrey M. Trent
    President and Research Director, Van Andel Research Institute; President and Research Director, The Translational Genomics Research Institute (TGen)
3:15 PM – 3:40 PM
3:45 PM – 4:10 PM
4:15 PM – 4:40 PM